ICD-10 Coding for Non-Hodgkin Lymphoma(C82.1, C82.90, C82.90U)
Comprehensive guide to ICD-10 coding for Non-Hodgkin Lymphoma, including specific codes, documentation requirements, and coding pitfalls.
Complete code families applicable to Non-Hodgkin Lymphoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C85.90 | Non-Hodgkin lymphoma, unspecified | Use when the specific subtype of NHL is not documented. |
|
| C83.30 | Diffuse large B-cell lymphoma, unspecified site | Use for active DLBCL when the site is not specified. |
|
| C83.3A | Diffuse large B-cell lymphoma in remission | Use when DLBCL is in remission. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutNon-Hodgkin Lymphoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Non-Hodgkin Lymphoma.
Documenting 'history of NHL' without specifying current status.
Impact
Clinical: May lead to inappropriate treatment planning., Regulatory: Non-compliance with documentation standards., Financial: Potential for incorrect billing.
Mitigation
Always specify if the disease is active or in remission., Use appropriate history codes when applicable.
Using unspecified codes when specific subtypes are documented.
Impact
Reimbursement: May lead to lower reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases the accuracy of patient records.
Mitigation
Always document and code the specific subtype of NHL.
Remission Status Documentation
Impact
Failure to document remission status accurately.
Mitigation
Implement regular audits of oncology documentation.